TipRanks
Advertisement
Advertisement

MX:AMGN Stock Latest News

Amgen says FDA approves update to imdelltra Prescribing Information
The FlyAmgen says FDA approves update to imdelltra Prescribing Information
10h ago
AMGN
Meta upgraded, Nvidia initiated: Wall Street’s top analyst calls
PremiumThe Fly
Meta upgraded, Nvidia initiated: Wall Street’s top analyst calls
4d ago
AS
UA
HSBC downgrades Amgen to Hold on fair value after re-rating
PremiumThe Fly
HSBC downgrades Amgen to Hold on fair value after re-rating
5d ago
AMGN
Amgen downgraded to Hold from Buy at HSBC
PremiumThe Fly
Amgen downgraded to Hold from Buy at HSBC
5d ago
AMGN
Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen
PremiumRatings
Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen
6d ago
AMGN
SpaceX initiated, Intel upgraded: Wall Street’s top analyst calls
PremiumThe FlySpaceX initiated, Intel upgraded: Wall Street’s top analyst calls
6d ago
BBY
LMT
Amgen, AstraZeneca report Phase 3 DeLLphi-305 study met primary endpoint
Premium
The Fly
Amgen, AstraZeneca report Phase 3 DeLLphi-305 study met primary endpoint
6d ago
AZN
AMGN
AstraZeneca announces results from Phase III trial of IMFINZI, tarlatamab
Premium
The Fly
AstraZeneca announces results from Phase III trial of IMFINZI, tarlatamab
6d ago
AZN
AMGN
Amgen downgraded to Market Perform from Outperform at BMO Capital
PremiumThe Fly
Amgen downgraded to Market Perform from Outperform at BMO Capital
7d ago
AMGN
Novartis pelacarsen miss ‘not great on the margin for’ Amgen, says UBS
PremiumThe Fly
Novartis pelacarsen miss ‘not great on the margin for’ Amgen, says UBS
7d ago
NVS
AMGN
Amgen price target raised to $435 from $400 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $435 from $400 at Wells Fargo
11d ago
AMGN
Amgen price target raised to $435 from $400 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $435 from $400 at Wells Fargo
11d ago
AMGN
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
PremiumTipRanks NewswireEntera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
14d ago
LLY
NVO
Amgen Repatha reduces risk of death in high-risk adults for first heart attack
Premium
The Fly
Amgen Repatha reduces risk of death in high-risk adults for first heart attack
15d ago
AMGN
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
Premium
The Fly
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
19d ago
AZN
AMGN
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
PremiumThe Fly
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
19d ago
AZN
AMGN
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
PremiumThe Fly
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
19d ago
AA
MT
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
PremiumThe Fly
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
20d ago
ABT
BMY
Amgen price target raised to $457 from $427 at Piper Sandler
PremiumThe Fly
Amgen price target raised to $457 from $427 at Piper Sandler
26d ago
AMGN
Amgen price target raised to $362 from $351 at Morgan Stanley
PremiumThe FlyAmgen price target raised to $362 from $351 at Morgan Stanley
26d ago
AMGN
Amgen price target raised to $460 from $375 at Argus
Premium
The Fly
Amgen price target raised to $460 from $375 at Argus
26d ago
AMGN
Amgen price target raised to $400 from $350 at Cantor Fitzgerald
Premium
The Fly
Amgen price target raised to $400 from $350 at Cantor Fitzgerald
27d ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >